PTK2 and breast cancer: miR-4731-5p can downregulate PAICS, decrease the levels of PKM2 and GLUT1, and inhibit the phosphorylation of FAK, thereby impeding the aerobic glycolysis of breast cancer cells and inhibiting tumor growth [36].